215
Views
48
CrossRef citations to date
0
Altmetric
Review

Safety of immunisation and adverse events following vaccination against hepatitis B

Pages 225-231 | Published online: 03 Mar 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shmuel Appel, Joab Chapman & Yehuda Shoenfeld. (2007) Infection and vaccination in chronic fatigue syndrome: Myth or reality?. Autoimmunity 40:1, pages 48-53.
Read now

Articles from other publishers (46)

Anna Kramvis, Ioannis Mammas & Demetrios Spandidos. (2023) Exploring the optimal vaccination strategy against hepatitis B virus in childhood (Review). Biomedical Reports 19:1.
Crossref
John W. Ward, Nasamon Wanlapakorn, Yong Poovorawan & Daniel Shouval. 2023. Plotkin's Vaccines. Plotkin's Vaccines 389 432.e21 .
Bianca Olivieri, Corrado Betterle & Giovanna Zanoni. (2021) Vaccinations and Autoimmune Diseases. Vaccines 9:8, pages 815.
Crossref
Vanitha Sampath, Grace Rabinowitz, Mihir Shah, Surabhi Jain, Zuzana Diamant, Milos Jesenak, Ronald Rabin, Stefan Vieths, Ioana Agache, Mübeccel Akdis, Domingo Barber, Heimo Breiteneder, Sharon Chinthrajah, Tomas Chivato, William Collins, Thomas Eiwegger, Katharine Fast, Wytske Fokkens, Robyn E. O'Hehir, Markus Ollert, Liam O'Mahony, Oscar Palomares, Oliver Pfaar, Carmen Riggioni, Mohamed H Shamji, Milena Sokolowska, Maria Jose Torres, Claudia Traidl‐Hoffmann, Menno Zelm, De Yun Wang, Luo Zhang, Cezmi A. Akdis & Kari C. Nadeau. (2021) Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives. Allergy 76:6, pages 1640-1660.
Crossref
John W. Ward. 2021. Hepatitis B Virus and Liver Disease. Hepatitis B Virus and Liver Disease 169 203 .
L. M. Khantimirova, T. Yu. Kozlova, E. L. Postnova, V. A. Shevtsov & A. V. Rukavishnikov. (2018) Retrospective Analysis of Viral Hepatitis B Incidence in Russia from 2013 to 2017 in the Context of Preventive Vaccination. BIOpreparations. Prevention, Diagnosis, Treatment 18:4, pages 225-235.
Crossref
Xiao-Hui Jin, Lan-Lan Zheng, Mei-Rong Song, Wei-Song Xu, Ya-Nan Kou, Yong Zhou, Li-Wei Zhang, Yan-Ning Zhu, Bo Wan, Zhan-Yong Wei & Gai-Ping Zhang. (2018) A nano silicon adjuvant enhances inactivated transmissible gastroenteritis vaccine through activation the Toll-like receptors and promotes humoral and cellular immune responses. Nanomedicine: Nanotechnology, Biology and Medicine 14:4, pages 1201-1212.
Crossref
Penina Haber, Pedro L. Moro, Carmen Ng, Paige W. Lewis, Beth Hibbs, Sarah F. Schillie, Noele P. Nelson, Rongxia Li, Brock Stewart & Maria V. Cano. (2018) Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005–2015. Vaccine 36:4, pages 559-564.
Crossref
Pierre Van Damme, John W. Ward, Daniel Shouval & Alessandro Zanetti. 2018. Plotkin's Vaccines. Plotkin's Vaccines 342 374.e17 .
John W. Ward & Pierre Van Damme. 2018. Hepatitis B Virus and Liver Disease. Hepatitis B Virus and Liver Disease 91 117 .
Ambujam N Kapoor, Prathap Tharyan, Lalit Kant, Vinohar Balraj & Ian Shemilt. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Berit Feiring, Ida Laake, Inger Johanne Bakken, Margrethe Greve-Isdahl, Vegard Bruun Wyller, Siri E. Håberg, Per Magnus & Lill Trogstad. (2017) HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway. Vaccine 35:33, pages 4203-4212.
Crossref
Qiudong Su, Yao Yi, Feng Qiu, Xuexin Lu, Junying Ding, Zhiyuan Jia, Ruiguang Tian, Yan Gao & Shengli Bi. (2015) Immune Responses to HBsAg Conjugated to Protein D of Non-Typeable Haemophilus influenzae in Mice. PLOS ONE 10:2, pages e0117736.
Crossref
Mohamed Ibrahim Saeed, Abd Rahaman Omar, Mohd Zobir Hussein, Isam Mohamed Elkhidir & Zamberi Sekawi. (2015) Systemic antibody response to nano-size calcium phospate biocompatible adjuvant adsorbed HEV-71 killed vaccine. Clinical and Experimental Vaccine Research 4:1, pages 88.
Crossref
Tamar A. Smith-Norowitz, Elizabeth Tam, Kevin B. Norowitz, Kobkul Chotikanatis, Diana Weaver, Helen G. Durkin, Martin H. Bluth & Stephan Kohlhoff. (2014) IgE anti Hepatitis B virus surface antigen antibodies detected in serum from inner city asthmatic and non asthmatic children. Human Immunology 75:4, pages 378-382.
Crossref
Ju Hui Han, Deog Gon Kim & Jin Yong Lee. (2014) A Case Report of Extensive Limb Swelling in Newborn After Vaccination: Unusual Thigh Swelling After Hepatitis B vaccination. The Journal of Korean Oriental Pediatrics 28:1, pages 52-60.
Crossref
Pierre Van Damme, John Ward, Daniel Shouval, Steven Wiersma & Alessandro Zanetti. 2013. Vaccines. Vaccines 205 234 .
Joerg-Patrick Stübgen. (2012) Immune-mediated myelitis following hepatitis B vaccination. Autoimmunity Reviews 12:2, pages 144-149.
Crossref
Kar Neng Lai. (2011) Hepatitis-related renal disease. Future Virology 6:11, pages 1361-1376.
Crossref
L. Dell'Era, S. Esposito, F. Corona & N. Principi. (2011) Vaccination of children and adolescents with rheumatic diseases. Rheumatology 50:8, pages 1358-1365.
Crossref
M. Weisser. (2010) Impfungen unter immunsuppressiver Therapie chronisch entzündlicher ErkrankungenVaccination under immunosuppressive therapy of chronic inflammatory diseases. Der Internist 52:3, pages 277-282.
Crossref
J.-F. Rahier, M. Moutschen, A. Van Gompel, M. Van Ranst, E. Louis, S. Segaert, P. Masson & F. De Keyser. (2010) Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology 49:10, pages 1815-1827.
Crossref
Ambujam N Kapoor, Prathap Tharyan, Lalit Kant, Vinohar Balraj & Ian Shemilt. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Joerg-Patrick Stübgen. (2010) Neuromuscular disorders associated with Hepatitis B vaccination. Journal of the Neurological Sciences 292:1-2, pages 1-4.
Crossref
Amelie Plymoth, Simonetta Viviani & Pierre Hainaut. (2009) Control of hepatocellular carcinoma through Hepatitis B vaccination in areas of high endemicity: Perspectives for global liver cancer prevention. Cancer Letters 286:1, pages 15-21.
Crossref
Per Magnus, Oddbjørn Brubakk, Harald Nyland, Borgny Hedvig Wold, Håkon K. Gjessing, Ingunn Brandt, Tove Eidem, Hanne Nøkleby & Geir Stene-Larsen. (2009) Vaccination as teenagers against meningococcal disease and the risk of the chronic fatigue syndrome. Vaccine 27:1, pages 23-27.
Crossref
Paul V. Targonski, Inna G. Ovsyannikova, Pritish K. Tosh, Robert M. Jacobson & Gregory A. Poland. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics 1247 1268 .
Agmon-Levin Nancy & Yehuda Shoenfeld. (2008) Chronic fatigue syndrome with autoantibodies — The result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant. Autoimmunity Reviews 8:1, pages 52-55.
Crossref
D. G. Ebo, C. H. Bridts & W. J. Stevens. (2008) IgE-mediated large local reaction from recombinant hepatitis B vaccine. Allergy 63:4, pages 483-484.
Crossref
Zurina Cinza Estévez, Arístides Aguilar Betancourt, Verena Muzio González, Nelvis Figueroa Baile, Carmen Valenzuela Silva, Francisco Hernández Bernal, Eduardo Pentón Arias, Aurora Delhanty Fernández, Nelia Martin Olazábal, Amaurys del Río Martín, Lester Leal Batista, Gloria Véliz Ríos, Héctor Hernández Hernández, Aracelis Blanco Hernández, Evelyn Pérez Lugo, Joel de la Torre Cruz, Bertha L. Batista Marchec, Leovaldo Álvarez Falcón, Jannet Trujillo Brito, Darién Ortega León & Pedro López Saura. (2007) Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adults. Biologicals 35:2, pages 115-122.
Crossref
Dr. Enrique IglesiasOrisley FranchYamilka CarrazanaYadira LobainaDaymir GarcíaJorge SanchezJosé GarcíaDioslaida UrquizaVerena MuzioGerardo GuillénJulio C. Aguilar. (2006) Influence of Aluminum-Based Adjuvant on the Immune Response to Multiantigenic Formulation. Viral Immunology 19:4, pages 712-721.
Crossref
Andrew SH Lai & Kar Neng Lai. (2006) Viral nephropathy. Nature Clinical Practice Nephrology 2:5, pages 254-262.
Crossref
Lluis Salleras, Miguel Bruguera & Andreu Prat. (2006) Vacuna de la hepatitis B y esclerosis múltiple: una asociación no probada. Medicina Clínica 126:15, pages 581-588.
Crossref
Lauren DiMiceli, Vitali Pool, John M. Kelso, Sean V. Shadomy, John Iskander & V.A.E.R.S. Team. (2006) Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS). Vaccine 24:6, pages 703-707.
Crossref
Terney Daniella, Beniczky Sándor, Barsi Péter, Kondákor István, Perényi József, Faludi Béla, Szapper Magdolna & Vécsei László. (2006) Multiple sclerosis after hepatitis B vaccination in a 16-year-old patient. Chinese Medical Journal 119:1, pages 77-79.
Crossref
. 2006. McAlpine's Multiple Sclerosis. McAlpine's Multiple Sclerosis 811 946 .
Guido Fran??ois, Philippe Duclos, Harold Margolis, Daniel Lavanchy, Claire-Anne Siegrist, Andr?? Meheus, Paul-Henri Lambert, Nedret Emiro??lu, Selim Badur & Pierre Van Damme. (2005) Vaccine Safety Controversies and the Future of Vaccination Programs. The Pediatric Infectious Disease Journal 24:11, pages 953-961.
Crossref
C. Confavreux, S. Vukusic, T. Arbizu, B. Brochet, M. Clanet, G. Edan, L. Kappos & S. Suissa. (2005) Sclérose en plaques et vaccination contre l’hépatite B chez l’adulte : le point en 2004. Revue Neurologique 161:6-7, pages 644-646.
Crossref
Ami Schattner. (2005) Consequence or coincidence?. Vaccine 23:30, pages 3876-3886.
Crossref
Gregory A. Poland & Robert M. Jacobson. (2004) Prevention of Hepatitis B with the Hepatitis B Vaccine. New England Journal of Medicine 351:27, pages 2832-2838.
Crossref
Benjamin J. Song & Rohit K. Katial. (2004) Update on side effects from common vaccines. Current Allergy and Asthma Reports 4:6, pages 447-453.
Crossref
Robert T. NaismithAnne H. Cross. (2004) Does the hepatitis B vaccine cause multiple sclerosis?. Neurology 63:5, pages 772-773.
Crossref
. 2004. Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach - Volume I: Principles and Methods of Immunotoxicology. Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach - Volume I: Principles and Methods of Immunotoxicology 55 126 .
Tomasz I. Michalak. 2004. Hepatitis Prevention and Treatment. Hepatitis Prevention and Treatment 87 105 .
N/A. (2003) N/A. World Chinese Journal of Digestology 11:11, pages 1764-1768.
Crossref
Philippe Duclos, Alison Delo, Teresa Aguado, Julian Bilous, Maureen Birmingham, Marie Paule Kieny, Julie Milstien, David Wood & Daniel Tarantola. (2003) Immunization safety priority project at the world health organization. Seminars in Pediatric Infectious Diseases 14:3, pages 233-239.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.